Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS)

Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS)

Bibliographic Details
Main Authors: Lum, Lawrence G, Choi, Minsig, Thakur, Archana, Deol, Abhinav, Fields, Kristie, Tomaszewski, Elyse, Schalk, Dana, Kondadasule, Vidya, Dyson, Greg, Mahaseth, Hemchandra, Philip, Philip, Shields, Anthony
Format: Online
Language:English
Published: BioMed Central 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645487/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645487/

Similar Items